Skip to main navigation Skip to search Skip to main content

HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab

  • Francesco Sclafani
  • , Amitesh Roy
  • , David Cunningham
  • , Andrew Wotherspoon
  • , Clare Peckitt
  • , David Gonzalez de Castro
  • , J Tabernero
  • , Bengt Glimelius
  • , Andres Cervantes
  • , Zak Eltahir
  • , Jacqueline Oates
  • , Ian Chau

    Research output: Contribution to journal › Article › peer-review

    31 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab'. Together they form a unique fingerprint.
    Sort by

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science